NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

26 hedge funds and large institutions have $1.08M invested in Navidea Biopharmaceuticals Inc. in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
5
Closed
3
Calls
$39K
Puts
$233K
Net Calls
-$194K
Net Calls Change
+$16K

Top Buyers

1
Simplex Trading
1
Simplex Trading
Illinois
$21K
2
TSS
2
Two Sigma Securities
New York
$10K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$9K
4
PP
4
PDS Planning
Ohio
$8K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$75K

Top Sellers

1
BlackRock
1
BlackRock
New York
$85K
2
VF
2
Virtu Financial
New York
$0
3
ACM
3
Allred Capital Management
Texas
$26K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$2K
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$0 105 – –
Wolverine Trading
27
Wolverine Trading
Illinois
– – – –
PA
28
Parallel Advisors
California
$0 350 – –
SIS
29
Sound Income Strategies
Florida
$0 599 – –
BCMLT
30
Beacon Capital Management LLC (Tennessee)
Tennessee
$0 10 – –
CAPTRUST Financial Advisors
31
CAPTRUST Financial Advisors
North Carolina
$0 4 – –
CA
32
CoreCap Advisors
Michigan
$0 45 +45 New
1
2